Singular Genomics Systems Inc reports results for the quarter ended in June - Earnings Summary

Singular Genomics Systems

09/08/2023 22:02

* Singular Genomics Systems Inc  OMIC.OQ  reported a
quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 37 cents per share.
    * Revenue was $505.00 thousand​; analysts expected $1.15
million. 
    * Singular Genomics Systems Inc's reported EPS for the
quarter was
a loss of 35 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Singular Genomics Systems Inc shares had fallen by 12.0%
this
quarter and lost 63.7% so far this year.
    * The company reported a quarterly loss of $25.58 million.
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $1.15 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.37          -0.35          Beat
 Mar. 31 2023      -0.35          -0.33          Beat
 Dec. 31 2022      -0.43          -0.29          Beat
 Sep. 30 2022      -0.41          -0.33          Beat